Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar V Parikh

Showing results (101-110 of 189) with videos related to

Pageof 19
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 24, 2023
Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL studySagar V Parikh, Scott T Aaronson, Sanjay J Mathew, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 23, 2005
Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scaleRoger S McIntyre, Jakub Z Konarski, Deborah A Mancini, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological TreatmentsSagar V Parikh, Lena C Quilty, Paula Ravitz, et al.
Psychiatry Research|May 10, 2023
The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 reportManish Dama, Michelle Wu, Vanessa K Tassone, et al.
The Journal of ECT|September 14, 2021
Electroconvulsive Therapy in Canada During the First Wave of COVID-19: Results of the "What Happened" National SurveyIlya Demchenko, Daniel M Blumberger, Alastair J Flint, et al.
The Journal of Clinical Psychiatry|May 8, 2025
Developing a Treatment-Resistant Depression Consultation Program, Part II: AssessmentJay C Fournier, Vitaliy L Voytenko, Anna R Docherty, et al.
The Journal of Clinical Psychiatry|May 2, 2025
Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical ConsiderationsVitaliy L Voytenko, Susan K Conroy, Anna R Docherty, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 14, 2023
The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 ReportKate L Harkness, Trisha Chakrabarty, Sakina J Rizvi, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of CareRaymond W Lam, Diane McIntosh, JianLi Wang, et al.
Brain and Behavior|March 25, 2022
Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapyCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Pageof 19

Showing results (101-110 of 189) with videos related to

Sort By:
Pageof 19
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 24, 2023
Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL studySagar V Parikh, Scott T Aaronson, Sanjay J Mathew, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 23, 2005
Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scaleRoger S McIntyre, Jakub Z Konarski, Deborah A Mancini, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological TreatmentsSagar V Parikh, Lena C Quilty, Paula Ravitz, et al.
Psychiatry Research|May 10, 2023
The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 reportManish Dama, Michelle Wu, Vanessa K Tassone, et al.
The Journal of ECT|September 14, 2021
Electroconvulsive Therapy in Canada During the First Wave of COVID-19: Results of the "What Happened" National SurveyIlya Demchenko, Daniel M Blumberger, Alastair J Flint, et al.
The Journal of Clinical Psychiatry|May 8, 2025
Developing a Treatment-Resistant Depression Consultation Program, Part II: AssessmentJay C Fournier, Vitaliy L Voytenko, Anna R Docherty, et al.
The Journal of Clinical Psychiatry|May 2, 2025
Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical ConsiderationsVitaliy L Voytenko, Susan K Conroy, Anna R Docherty, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 14, 2023
The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 ReportKate L Harkness, Trisha Chakrabarty, Sakina J Rizvi, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of CareRaymond W Lam, Diane McIntosh, JianLi Wang, et al.
Brain and Behavior|March 25, 2022
Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapyCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Pageof 19